164 related articles for article (PubMed ID: 35906789)
1. Overlapping acute generalized exanthematous pustulosis drug reaction with eosinophilia and systemic symptoms induced by a second dose of the Moderna COVID-19 vaccine.
Ikeda T; Yokoyama K; Kawakami T
J Dermatol; 2022 Dec; 49(12):e446-e447. PubMed ID: 35906789
[No Abstract] [Full Text] [Related]
2. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with skin eruptions mimicking acute generalized exanthematous pustulosis.
Goto T; Kogure A; Kuwano Y
J Dermatol; 2022 Jan; 49(1):e16-e17. PubMed ID: 34626006
[No Abstract] [Full Text] [Related]
3. Demographic and laboratory differences seen between acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms: A cross-sectional analysis.
Gallardo MA; Mallela T; Gilkey T; Himed S; Walker TD; Nusbaum KB; Korman A; Trinidad J; Chung C; Kaffenberger BH
J Am Acad Dermatol; 2023 May; 88(5):1142-1145. PubMed ID: 36442643
[No Abstract] [Full Text] [Related]
4. Allopurinol-induced drug rash with eosinophilia and systemic symptoms mimicking acute generalized exanthematous pustulosis.
Huang YC; Shih PY; Chin SY; Chiang YY
J Dermatol; 2012 Dec; 39(12):1077-8. PubMed ID: 22901319
[No Abstract] [Full Text] [Related]
5. Severe acute generalized exanthematous pustulosis (AGEP) induced by miconazole oral gel with overlapping features of drug reaction with eosinophilia and systemic symptoms (DRESS).
Tedbirt B; Viart-Commin MH; Carvalho P; Courville P; Tétart F
Contact Dermatitis; 2021 Jun; 84(6):474-476. PubMed ID: 33382118
[No Abstract] [Full Text] [Related]
6. [CME. Severe cutaneous drug reaction].
Deuel J; Schaer D; Schmid-Grendelmeier P; Vallelian F
Praxis (Bern 1994); 2014 Oct; 103(21):1231-43. PubMed ID: 25305114
[No Abstract] [Full Text] [Related]
7. Koebnerization of Hailey-Hailey disease into a cutaneous drug eruption of acute generalized exanthematous pustulosis associated with systemic symptoms.
Totonchy MB; McNiff JM; Bunick CG
J Cutan Pathol; 2016 Nov; 43(11):1031-1035. PubMed ID: 27433827
[TBL] [Abstract][Full Text] [Related]
8. Multiple drug hypersensitivity syndrome manifesting as acute generalised exanthematous pustulosis: A rare case report.
Bragança M; Brandão Abreu D; Moço Coutinho R; Rodrigues Cernadas J; Carneiro-Leão L
Contact Dermatitis; 2024 Apr; 90(4):439-441. PubMed ID: 38234058
[No Abstract] [Full Text] [Related]
9. [The major SCAR syndromes].
Piérard GE; Lesuisse M; Piérard-Franchimont C
Rev Med Liege; 2017 Oct; 72(10):444-447. PubMed ID: 29058836
[TBL] [Abstract][Full Text] [Related]
10. Severe cutaneous adverse reactions to drugs.
Duong TA; Valeyrie-Allanore L; Wolkenstein P; Chosidow O
Lancet; 2017 Oct; 390(10106):1996-2011. PubMed ID: 28476287
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of severe drug hypersensitivity.
Dodiuk-Gad RP; Laws PM; Shear NH
Semin Cutan Med Surg; 2014 Mar; 33(1):2-9. PubMed ID: 25037253
[TBL] [Abstract][Full Text] [Related]
12. Utility of patch testing for the diagnosis of delayed-type drug hypersensitivity reactions to clindamycin.
Gilissen L; Huygens S; Goossens A; Breynaert C; Schrijvers R
Contact Dermatitis; 2020 Sep; 83(3):237-239. PubMed ID: 32333605
[No Abstract] [Full Text] [Related]
13. Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).
Owen CE; Jones JM
Med Clin North Am; 2021 Jul; 105(4):577-597. PubMed ID: 34059239
[TBL] [Abstract][Full Text] [Related]
14. Severe cutaneous adverse reactions.
Hung SI; Mockenhaupt M; Blumenthal KG; Abe R; Ueta M; Ingen-Housz-Oro S; Phillips EJ; Chung WH
Nat Rev Dis Primers; 2024 Apr; 10(1):30. PubMed ID: 38664435
[TBL] [Abstract][Full Text] [Related]
15. First case of DRESS syndrome attributed to a spider bite.
Eyraud A; Boursault L; Darrigade AS; Taieb A; Milpied B
J Allergy Clin Immunol Pract; 2017; 5(4):1135-1136. PubMed ID: 28017625
[No Abstract] [Full Text] [Related]
16. COVID-19 vaccine-induced acute generalized exanthematous pustulosis.
Kang SY; Park SY; Kim JH; Lee SM; Lee SP
Korean J Intern Med; 2021 Nov; 36(6):1537-1538. PubMed ID: 34130372
[No Abstract] [Full Text] [Related]
17. Severe Cutaneous Drug Reactions: Do Overlapping Forms Exist?
Horcajada-Reales C; Pulido-Pérez A; Suárez-Fernández R
Actas Dermosifiliogr; 2016; 107(1):23-33. PubMed ID: 26520037
[TBL] [Abstract][Full Text] [Related]
18. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.
Lee HY; Chou D; Pang SM; Thirumoorthy T
Int J Dermatol; 2010 May; 49(5):507-12. PubMed ID: 20534083
[TBL] [Abstract][Full Text] [Related]
19. Acute Generalized Exanthematous Pustulosis in Close Temporal Association with mRNA-1273 Vaccine.
Mitri F; Toberer F; Enk AH; Hartmann M
Acta Derm Venereol; 2021 Nov; 101(11):adv00596. PubMed ID: 34708247
[No Abstract] [Full Text] [Related]
20. Treatments for Severe Cutaneous Adverse Reactions.
Cho YT; Chu CY
J Immunol Res; 2017; 2017():1503709. PubMed ID: 29445753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
